G5M

(2S)-2-{[2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid

Created:	2018-05-08
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where G5M is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	7
Bond Count	48
Aromatic Bond Count	0

2D diagram of G5M

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-2-{[2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranosyl]oxy}butanedioic acid
Systematic Name (OpenEye OEToolkits)	(2~{S})-2-[(2~{R},3~{R},4~{R},5~{S},6~{R})-3-[[(2~{R})-2-azanyl-3-sulfanyl-propanoyl]amino]-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxybutanedioic acid
Formula	C₁₃ H₂₂ N₂ O₁₀ S
Molecular Weight	398.386
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C(NC1C(OC(CC(O)=O)C(O)=O)OC(C(O)C1O)CO)(C(CS)N)=O
SMILES	CACTVS	3.385	N[CH](CS)C(=O)N[CH]1[CH](O)[CH](O)[CH](CO)O[CH]1O[CH](CC(O)=O)C(O)=O
SMILES	OpenEye OEToolkits	2.0.6	C(C1C(C(C(C(O1)OC(CC(=O)O)C(=O)O)NC(=O)C(CS)N)O)O)O
Canonical SMILES	CACTVS	3.385	N[C@@H](CS)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H](CC(O)=O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.6	C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N)O)O)O
InChI	InChI	1.03	InChI=1S/C13H22N2O10S/c14-4(3-26)11(21)15-8-10(20)9(19)6(2-16)25-13(8)24-5(12(22)23)1-7(17)18/h4-6,8-10,13,16,19-20,26H,1-3,14H2,(H,15,21)(H,17,18)(H,22,23)/t4-,5-,6+,8+,9+,10+,13-/m0/s1
InChIKey	InChI	1.03	UHNHELGKNQMNGF-AOQKXWSCSA-N

Related Resource References

Resource Name	Reference
PubChem	42614123
ChEBI	CHEBI:61338

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.